.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Covington
Dow
Chubb
QuintilesIMS
Express Scripts
UBS
Novartis
Healthtrust
Baxter

Generated: January 19, 2018

DrugPatentWatch Database Preview

Patents Expiring in January 2023

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novartis Pharms CorpZYKADIAceritinibCAPSULE;ORAL205755-001Apr 29, 2014RXYesYes➤ Subscribe➤ SubscribeYY
Novartis Pharms CorpZYKADIAceritinibCAPSULE;ORAL205755-001Apr 29, 2014RXYesYes➤ Subscribe➤ SubscribeYY
Novartis Pharms CorpZYKADIAceritinibCAPSULE;ORAL205755-001Apr 29, 2014RXYesYes➤ Subscribe➤ SubscribeYY
Novartis Pharms CorpZYKADIAceritinibCAPSULE;ORAL205755-001Apr 29, 2014RXYesYes➤ Subscribe➤ SubscribeYY
Sanofi Aventis UsAPIDRAinsulin glulisine recombinantINJECTABLE;IV (INFUSION), SUBCUTANEOUS021629-002Dec 20, 2005RXYesYes➤ Subscribe➤ SubscribeYMETHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS
Sanofi Aventis UsAPIDRAinsulin glulisine recombinantINJECTABLE;IV (INFUSION), SUBCUTANEOUS021629-001Apr 16, 2004RXYesYes➤ Subscribe➤ SubscribeYMETHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS
Sanofi Aventis UsAPIDRA SOLOSTARinsulin glulisine recombinantINJECTABLE;SUBCUTANEOUS021629-003Feb 24, 2009RXYesNo➤ Subscribe➤ SubscribeYMETHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS
Ge HealthcareVIZAMYLflutemetamol f-18INJECTABLE;INTRAVENOUS203137-002Oct 25, 2013RXYesYes➤ Subscribe➤ SubscribeYYDIAGNOSTIC RADIOIMAGING
Ge HealthcareVIZAMYLflutemetamol f-18INJECTABLE;INTRAVENOUS203137-002Oct 25, 2013RXYesYes➤ Subscribe➤ SubscribeDIAGNOSTIC RADIOIMAGING
Ge HealthcareVIZAMYLflutemetamol f-18INJECTABLE;INTRAVENOUS203137-001Oct 25, 2013RXYesYes➤ Subscribe➤ SubscribeYYDIAGNOSTIC RADIOIMAGING
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Novartis
Deloitte
Federal Trade Commission
Argus Health
Accenture
Healthtrust
McKinsey
Teva
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot